In these tumors, an anti-tumor immune response appears to have been initiated, but then inhibited (presumably by upregulation of T cell inhibitory receptors like PD1 and CTLA-4), that was then “unleashed” by checkpoint blockade. This evidence concerns the gene CTLA4 and neoplasm.